Panagora Asset Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Panagora Asset Management’s Portfolio MRTX Stock Details MRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-893	Closed	-$144K	–	2492
2021 Q2	$144K	Buy	893 +28	+3%	+$4.5K	﹤0.01%	1754
2021 Q1	$148K	Hold	865	–	–	﹤0.01%	1801
2020 Q4	$190K	Buy	+865	New	+$187K	﹤0.01%	1608
2017 Q2	–	Sell	-104,143	Closed	-$542K	–	2677
2017 Q1	$542K	Buy	104,143 +35,868	+53%	+$197K	﹤0.01%	1357
2016 Q4	$324K	Buy	+68,275	New	+$371K	﹤0.01%	1595
2016 Q1	–	Sell	-1,390	Closed	-$44K	–	2353
2015 Q4	$44K	Sell	1,390 -5,032	-78%	-$178K	﹤0.01%	2010
2015 Q3	$221K	Buy	6,422 +4,751	+284%	+$144K	﹤0.01%	1576
2015 Q2	$53K	Buy	+1,671	New	+$49.2K	﹤0.01%	2128

Other funds holding MRTX

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Aviva Holdings New Providence, Bahamas $20.5M AUM 117.01% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Panagora Asset Management's MRTX Position: Q3 2021 in Review

Panagora Asset Management sold out of Mirati Therapeutics, Inc. Common Stock (MRTX) in Q3 2021, closing a stake of 893 shares — an estimated $144K sold.

Panagora Asset Management first reported a position in MRTX in Q2 2015 and held it in 8 quarters. The position peaked at $542K in Q1 2017. 238 funds tracked by Wall St. Rank hold MRTX as of Q3 2021.

Panagora Asset Management reported no remaining Mirati Therapeutics, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
Panagora Asset Management sold 893 Mirati Therapeutics, Inc. Common Stock shares in Q3 2021, an estimated $144K.
Panagora Asset Management first reported a position in Mirati Therapeutics, Inc. Common Stock in Q2 2015 and held it in 8 quarters.
Panagora Asset Management's Mirati Therapeutics, Inc. Common Stock position peaked at $542K in Q1 2017.
238 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q3 2021.

Based on Panagora Asset Management's 13F filing for Q3 2021, filed 10 Nov 2021.